Coherus Oncology, Inc. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
Coherus Oncology, Inc. (CHRS) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$13.18 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-10.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2018-05-10
- Coherus Oncology, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2018-03-31 was -$13.18M.
- Coherus Oncology, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-12-31 was $14.39M.
- Coherus Oncology, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-09-30 was $28.71M.
- Coherus Oncology, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was $4.06M.
- Coherus Oncology, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2017 was -$4.42M.
- Coherus Oncology, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$6.51M.
- Coherus Oncology, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$6.95M.
- Coherus Oncology, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$525.00K.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2018-03-31 | -$13.18M 10-Q · filed 2018-05-10 | $1.21M derived: sum of 2 quarters · filed 2018-05-10 | $29.92M derived: sum of 3 quarters · filed 2018-05-10 | $33.98M derived: sum of 4 quarters · filed 2018-05-10 |
| 2017-12-31 | $14.39M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $43.10M derived: sum of 2 quarters · filed 2018-03-08 | $47.16M derived: sum of 3 quarters · filed 2018-03-08 | -$4.42M 10-K · filed 2018-03-08 |
| 2017-09-30 | $28.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | $32.77M derived: sum of 2 quarters · filed 2017-11-06 | -$18.81M 10-Q · filed 2017-11-06 | -$22.37M derived: sum of 4 quarters · filed 2018-05-10 |
| 2017-06-30 | $4.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | -$47.51M 10-Q · filed 2017-08-07 | -$51.08M derived: sum of 3 quarters · filed 2018-05-10 | -$51.58M derived: sum of 4 quarters · filed 2018-05-10 |
| 2017-03-31 | -$51.58M 10-Q · filed 2018-05-10 | -$55.14M derived: sum of 2 quarters · filed 2018-05-10 | -$55.64M derived: sum of 3 quarters · filed 2018-05-10 | -$55.95M derived: sum of 4 quarters · filed 2018-05-10 |
| 2016-12-31 | -$3.57M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | -$4.07M derived: sum of 2 quarters · filed 2018-03-08 | -$4.37M derived: sum of 3 quarters · filed 2018-03-08 | -$6.51M 10-K · filed 2018-03-08 |
| 2016-09-30 | -$500.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | -$801.00K derived: sum of 2 quarters · filed 2017-11-06 | -$2.95M 10-Q · filed 2017-11-06 | -$4.39M derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-06-30 | -$301.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | -$2.45M 10-Q · filed 2017-08-07 | -$3.89M derived: sum of 3 quarters · filed 2018-03-08 | -$7.08M derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-03-31 | -$2.15M 10-Q · filed 2017-05-08 | -$3.59M derived: sum of 2 quarters · filed 2018-03-08 | -$6.78M derived: sum of 3 quarters · filed 2018-03-08 | -$7.78M derived: sum of 4 quarters · filed 2018-03-08 |
| 2015-12-31 | -$1.44M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | -$4.63M derived: sum of 2 quarters · filed 2018-03-08 | -$5.64M derived: sum of 3 quarters · filed 2018-03-08 | -$6.95M 10-K · filed 2018-03-08 |
| 2015-09-30 | -$3.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$4.19M derived: sum of 2 quarters · filed 2016-11-09 | -$5.50M 10-Q · filed 2016-11-09 | -$6.00M derived: sum of 4 quarters · filed 2017-03-14 |
| 2015-06-30 | -$1.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | -$2.32M 10-Q · filed 2016-08-09 | -$2.82M derived: sum of 3 quarters · filed 2017-03-14 | -$3.63M derived: sum of 4 quarters · filed 2017-03-14 |
| 2015-03-31 | -$1.31M 10-Q · filed 2016-05-09 | -$1.81M derived: sum of 2 quarters · filed 2017-03-14 | -$2.62M derived: sum of 3 quarters · filed 2017-03-14 | -$3.91M derived: sum of 4 quarters · filed 2017-03-14 |
| 2014-12-31 | -$499.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | -$1.31M derived: sum of 2 quarters · filed 2017-03-14 | -$2.60M derived: sum of 3 quarters · filed 2017-03-14 | -$525.00K 10-K · filed 2017-03-14 |
| 2014-09-30 | -$807.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | -$2.10M derived: sum of 2 quarters · filed 2015-11-10 | -$26.00K 10-Q · filed 2015-11-10 | -$174.00K derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | -$1.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $781.00K 10-Q · filed 2015-08-10 | $633.00K derived: sum of 3 quarters · filed 2016-02-29 | |
| 2014-03-31 | $2.07M 10-Q · filed 2015-05-11 | $1.93M derived: sum of 2 quarters · filed 2016-02-29 | ||
| 2013-12-31 | -$148.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$373.00K 10-K · filed 2016-02-29 | ||
| 2013-09-30 | -$225.00K 10-Q · filed 2014-12-15 | |||
| 2012-12-31 | -$1.82M 10-K · filed 2015-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |